MedTrace Logo

Effect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity

NCT07715409 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2026-07-20

No results posted yet for this study

Summary

This randomized controlled trial aims to evaluate the efficacy of preoperative vaginal cleansing with 5% povidone-iodine in reducing postoperative infectious morbidity among women undergoing cesarean section. The primary outcomes include wound-related complications, while secondary outcomes include postoperative fever, endometritis, wound infection, and white blood cell count.

Conditions

  • Cesarean Section
  • Surgical Site Infection
  • Endometritis

Interventions

DRUG

Povidone-iodine 5% solution

Vaginal cleansing with 5% povidone-iodine for 30 seconds before cesarean section.

Sponsors & Collaborators

  • Mohamed Mousa Mohamed Mousa

    lead OTHER

Principal Investigators

  • ahmed shafik ibrahim · abdelrouf

  • ahmed shafik ibrahim

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2027-05-01
Primary Completion
2027-05-01
Completion
2027-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07715409 on ClinicalTrials.gov